跳至主要内容
临床试验/PACTR202309805784870
PACTR202309805784870已完成Unknown

Pain Management in Post-Caesarean Sections: Nefopam vs. Pethidine

Self0 个研究点目标入组 144 人开始时间: 2023年9月4日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
Self
入组人数
144

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • ? All ASA II and III patients at term gestation for elective Caesarean section under subarachnoid block. ASA II and III are contradictions to what are labelled as exclusion criteria (PUD, DM and uncontrolled hypertension) .

排除标准

  • ? Patient’s refusal to give written informed consent.
  • ? Patients with known allergy or sensitivity to the study medication
  • ? Present or past history of peptic ulcer disease
  • ? Contraindications to spinal anaesthesia
  • ? Diabetes mellitus Type 1 or 2
  • ? Systemic infection,
  • ?Patients with coexisting hepatic, renal, or cardiovascular disease.
  • ?History of chronic pain.
  • ?Opioid use 48hours preceding surgery.
  • ?Antenatal diagnosis of foetal abnormality
  • ?Known IV drug users.
  • ?Liver cirrhosis
  • ?Psychiatric illnesses
  • ?Patients on antiviral medications or live vaccines
  • ?Uncontrolled hypertension
  • ?Requiring more than 100mg IV Tramadol for treatment of breakthrough pain

研究者

发起方
Self

相似试验

A Comparative Study Of Nefopam-Dexamethasone And... | 临床试验